Eden Research plc

November 11, 2009 02:00 ET

Licensee Update

                                                                                      11 November 2009

                                           EDEN RESEARCH PLC
                                         ("Eden" or "Company")

                                            Licensee Update

In  the summer of 2009, Eden provided a sample of its lead product, 3AEY, to the Horticulture Research
Institute  in  Egypt  to  conduct the first in a series of field trials  on  behalf  of  Environmental
Solutions North Africa Limited, (ESNA) our partner in North Africa.

Samples  collected  from  the  three locations indicated that all the  grape  varieties  had  complete
protection  from  Botrytis  after  treating with 3AEY and provided  a  positive  effect  by  enhancing
vegetative  growth and chlorophyll content. 3AEY also improved anthocyanin content in  the  red  grape
varieties and improved the grape bunch quality when compared to the standard commercial application by
increasing berry weight and size, berry length and diameter for the different varieties tested.

For    trial    data    results    please   visit   http://www.edenresearch.co.uk/html/products/trial-

Clive Newitt, Managing Director of Eden Research plc, said:

"The  results once again demonstrate the excellent activity seen with 3AEY in controlling the Botrytis
disease  and there is further work planned by ESNA in other fruit and vegetable crops to be  initiated
in the near future."

Ian Redford, Chief Executive of ESNA, said:

"I  am  very  pleased with these results and am encouraged by the potential that this shows  for  both
Africa and the Middle East."

The directors of Eden Research plc are responsible for the content of this announcement.


Eden Research plc
Clive Newitt, Managing Director                                           01993 862761

St Helens Capital Partners LLP                                            020 7368 6959
Mark Anwyl or Duncan Vasey

Contact Information

  • Eden Research plc